208 related articles for article (PubMed ID: 19177313)
41. A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
Bailly-Chouriberry L; Cormant F; Garcia P; Lönnberg M; Szwandt S; Bondesson U; Popot MA; Bonnaire Y
Analyst; 2012 May; 137(10):2445-53. PubMed ID: 22454833
[TBL] [Abstract][Full Text] [Related]
42. Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS.
Reichel C
J Mass Spectrom; 2008 Jul; 43(7):916-23. PubMed ID: 18576436
[TBL] [Abstract][Full Text] [Related]
43. Applications and biomonitoring issues of recombinant erythropoietins for doping control.
Tsitsimpikou C; Kouretas D; Tsarouhas K; Fitch K; Spandidos DA; Tsatsakis A
Ther Drug Monit; 2011 Feb; 33(1):3-13. PubMed ID: 21099742
[TBL] [Abstract][Full Text] [Related]
44. The analytical approach for detection of carbamylated erythropoietin for doping control purposes.
Kaliszewski P; Siek P; Zalewska Z; Michalak D; Kwiatkowska D
Drug Test Anal; 2020 Nov; 12(11-12):1599-1604. PubMed ID: 33119952
[TBL] [Abstract][Full Text] [Related]
45. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
[TBL] [Abstract][Full Text] [Related]
46. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Schumacher YO; Saugy M; Pottgiesser T; Robinson N
Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
[TBL] [Abstract][Full Text] [Related]
47. Doping control analysis of insulin and its analogues in equine plasma by liquid chromatography-tandem mass spectrometry.
Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
J Chromatogr A; 2008 Aug; 1201(2):183-90. PubMed ID: 18501368
[TBL] [Abstract][Full Text] [Related]
48. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
[TBL] [Abstract][Full Text] [Related]
49. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
[TBL] [Abstract][Full Text] [Related]
50. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
Kolmonen M; Leinonen A; Pelander A; Ojanperä I
Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
[TBL] [Abstract][Full Text] [Related]
51. Quantification of 19-nortestosterone sulphate and boldenone sulphate in urine from male horses using liquid chromatography/tandem mass spectrometry.
Grace PB; Drake EC; Teale P; Houghton E
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):2999-3007. PubMed ID: 18777513
[TBL] [Abstract][Full Text] [Related]
52. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Kwok WH; Ho EN; Lau MY; Leung GN; Wong AS; Wan TS
Anal Bioanal Chem; 2013 Mar; 405(8):2595-606. PubMed ID: 23318763
[TBL] [Abstract][Full Text] [Related]
53. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
[TBL] [Abstract][Full Text] [Related]
54. Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison.
Hintikka L; Kuuranne T; Leinonen A; Thevis M; Schänzer W; Halket J; Cowan D; Grosse J; Hemmersbach P; Nielen MW; Kostiainen R
J Mass Spectrom; 2008 Jul; 43(7):965-73. PubMed ID: 18563858
[TBL] [Abstract][Full Text] [Related]
55. Liquid chromatography - high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control.
Joré C; Loup B; Garcia P; Paris AC; Popot MA; Audran M; Bonnaire Y; Varlet-Marie E; Bailly-Chouriberry L
J Chromatogr A; 2017 Oct; 1521():90-99. PubMed ID: 28941809
[TBL] [Abstract][Full Text] [Related]
56. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching.
Deventer K; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2005; 19(2):90-8. PubMed ID: 15584083
[TBL] [Abstract][Full Text] [Related]
58. Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry.
Deventer K; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2006; 20(5):877-82. PubMed ID: 16470715
[TBL] [Abstract][Full Text] [Related]
59. Qualitative detection of desmopressin in plasma by liquid chromatography-tandem mass spectrometry.
Esposito S; Deventer K; T'Sjoen G; Vantilborgh A; Delbeke FT; Goessaert AS; Everaert K; Van Eenoo P
Anal Bioanal Chem; 2012 Mar; 402(9):2789-96. PubMed ID: 22318696
[TBL] [Abstract][Full Text] [Related]
60. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
Segura J; Pascual JA; Gutiérrez-Gallego R
Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
